Calidi announces common stock offering, no amount given

Calidi (CLDI) Biotherapeutics announced that it intends to offer to sell shares of its common stock in an public offering. All of the shares of common stock are to be sold by the company. Calidi intends to use the net proceeds from the offering for working capital and for general corporate purposes. Ladenburg Thalmann & Co. Inc. is acting as exclusive placement agent for the offerings.